Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial
PaperCitations, authors & open-access status
Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 16 citations, 2026 year and hybrid oa status.
16
Citations
2026
Year
hybrid
OA Status